Search research articles
Contact Us
Filters
Showing results (21-30 of 133) with videos related to
Page
of 14
Sort By:
Expert Review of Clinical Pharmacology
|
April 19, 2014
Vintafolide (EC145) for the treatment of folate-receptor-α positive platinum-resistant ovarian cancer
Allison J Ambrosio, Daphne Suzin, Edwin L Palmer, et al.
Seminars in Radiation Oncology
|
December 1, 2015
Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2
Jennifer Scalia-Wilbur, Bradley L Colins, Richard T Penson, et al.
The Oncologist
|
June 30, 2010
Connection: Schwartz Center Rounds at Massachusetts General Hospital Cancer Center
Richard T Penson, Lidia Schapira, Sally Mack, et al.
Gynecologic Oncology
|
October 16, 2014
Primary debulking surgery for advanced ovarian cancer: are you a believer or a dissenter?
John O Schorge, Rachel M Clark, Susanna I Lee, et al.
The Oncologist
|
June 18, 2002
When does the responsibility of our care end: bereavement
Richard T Penson, Kara M Green, Bruce A Chabner, et al.
The Oncologist
|
June 22, 2005
Learning to cope: how far is too close?
Brian M Wolpin, Bruce A Chabner, Thomas J Lynch, et al.
The Oncologist
|
May 25, 2006
Teams: communication in multidisciplinary care
Richard T Penson, Helena Kyriakou, Dan Zuckerman, et al.
Cancers
|
March 13, 2024
PARP Inhibitors: Strategic Use and Optimal Management in Ovarian Cancer
Nicholas Hirschl, Wildnese Leveque, Julia Granitto, et al.
Anticancer Research
|
April 12, 2003
beta tubulin mutations are rare in human ovarian carcinoma
Diana E Lamendola, Zhenfeng Duan, Richard T Penson, et al.
The Oncologist
|
March 30, 2004
Help me help you: support groups in cancer therapy
Richard T Penson, Shivali H G Talsania, Bruce A Chabner, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 133) with videos related to
Sort By:
Page
of 14
Expert Review of Clinical Pharmacology
|
April 19, 2014
Vintafolide (EC145) for the treatment of folate-receptor-α positive platinum-resistant ovarian cancer
Allison J Ambrosio, Daphne Suzin, Edwin L Palmer, et al.
Seminars in Radiation Oncology
|
December 1, 2015
Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2
Jennifer Scalia-Wilbur, Bradley L Colins, Richard T Penson, et al.
The Oncologist
|
June 30, 2010
Connection: Schwartz Center Rounds at Massachusetts General Hospital Cancer Center
Richard T Penson, Lidia Schapira, Sally Mack, et al.
Gynecologic Oncology
|
October 16, 2014
Primary debulking surgery for advanced ovarian cancer: are you a believer or a dissenter?
John O Schorge, Rachel M Clark, Susanna I Lee, et al.
The Oncologist
|
June 18, 2002
When does the responsibility of our care end: bereavement
Richard T Penson, Kara M Green, Bruce A Chabner, et al.
The Oncologist
|
June 22, 2005
Learning to cope: how far is too close?
Brian M Wolpin, Bruce A Chabner, Thomas J Lynch, et al.
The Oncologist
|
May 25, 2006
Teams: communication in multidisciplinary care
Richard T Penson, Helena Kyriakou, Dan Zuckerman, et al.
Cancers
|
March 13, 2024
PARP Inhibitors: Strategic Use and Optimal Management in Ovarian Cancer
Nicholas Hirschl, Wildnese Leveque, Julia Granitto, et al.
Anticancer Research
|
April 12, 2003
beta tubulin mutations are rare in human ovarian carcinoma
Diana E Lamendola, Zhenfeng Duan, Richard T Penson, et al.
The Oncologist
|
March 30, 2004
Help me help you: support groups in cancer therapy
Richard T Penson, Shivali H G Talsania, Bruce A Chabner, et al.
Page
of 14